Nutritional Properties, Antioxidant and Anti-Acetylcholinesterase Activities of Pleurotus ostreatus

Article Preview

Abstract:

Pleurotus ostreatus, the worldwide edible mushroom, has a potent economic values and medicinal properties. In this study, nutritional properties, antioxidant, and anti-acetylcholinesterase activities of P. ostreatus were investigated. The extracts were prepared by maceration and soxhlet extraction with ethanol and decoction with distilled water. Nutritional analysis showed that P. ostreatus has high content of fibers (45.5%), proteins (20.8%) and carbohydrates (68.4%) with low content of lipids (0.56%). HPLC analysis revealed that P. ostreatus has high content of the potential health promoting of β-glucan (42.8%). Acetylcholinesterase (AChE) is a key enzyme in nervous system. Inhibition of this enzyme is used for the symptomatic treatment of Alzheimer’s disease (AD), the most common disease in aging population. Ellman colorimetric method was used to determine Acetylcholinesterase inhibitory (AChEI) activity. All extracts found containing high AChEI activity (IC50 = 1.75-5.91 mg/ml). Oxidative stress plays a major role in the pathogenesis of AD, thus antioxidant activity was also performed in this study. DPPH assay exhibited all P. ostreatus extracts had high antioxidant activity (IC50 = 0.59-5.47 mg/ml). The results suggested that P. ostreatus should be beneficial for AD treatment and the most efficient nutraceutical and functional foods.

You might also be interested in these eBooks

Info:

Periodical:

Pages:

14-20

Citation:

Online since:

May 2019

Export:

Price:

Permissions CCC:

Permissions PLS:

Сopyright:

© 2019 Trans Tech Publications Ltd. All Rights Reserved

Share:

Citation:

* - Corresponding Author

[1] K. Piska, K. Sułkowska-Ziaja, B. Muszyńska, Edible mushroom Pleurotus ostreatus (oyster mushroom) - its dietary significance and biological activity, Acta Sci. Pol. Hortorum Cultus. 16 (2017) 151-161.

DOI: 10.24326/asphc.2018.2.16

Google Scholar

[2] M. Ahmed, N. Abdullah, K.U. Ahmed, B. Bhuyan, Yield and nutritional composition of oyster mushroom strains newly introduced in Bangladesh, Pesq. agropec. bras., Brasília. 48:2 (2013) 197-202.

DOI: 10.1590/s0100-204x2013000200010

Google Scholar

[3] N. Alam, R. Amin, A. Khan, I. Ara, M.J. Shim, M.W. Lee, T.S. Lee, Nutritional Analysis of Cultivated Mushrooms in Bangladesh - Pleurotus ostreatus, Pleurotus sajor-caju, Pleurotus florida and Calocybe indica, Mycobiology. 36:4 (2008) 228-32.

DOI: 10.4489/myco.2008.36.4.228

Google Scholar

[4] K. Deepalakshmi, S. Mirunalini, Pleurotus ostreatus: an oyster mushroom with nutritional and medicinal properties, J Biochem Tech. 5:2 (2014) 718-26.

Google Scholar

[5] P. Taylor, S. Camp, Z. Radić, Acetylcholinesterase, in L.R. Squire (Eds), Encyclopedia of Neuroscience, Elsevier, 2009 p.5–7.

Google Scholar

[6] V.P. Reddy, Fluorinated Compounds in Enzyme-Catalyzed Reactions, in V.P. Reddy (Eds), Organofluorine Compounds in Biology and Medicine, Elsevier, 2015 p.29–57.

DOI: 10.1016/b978-0-444-53748-5.00002-2

Google Scholar

[7] A.A. Hamid, O.O. Aiyelaagbe, L.A. Usman, O.M. Ameen, A. Lawal, Antioxidants: Its medicinal and pharmacological applications, Afr. J. Pure Appl. Chem. 4:8 (2010) 142.

Google Scholar

[8] M.A. Smith, C.A. Rottkamp, A. Nunomura, A.K. Raina, G. Perry, Oxidative stress in Alzheimer's disease, BBA-Mol Basis Dis. 1502:1 (2000) 139-44.

DOI: 10.1016/s0925-4439(00)00040-5

Google Scholar

[9] G.L. Ellman, D.K. Courtney, V. Andres jr., R.M. Featherstone, A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 7:2 (1961) 88–95.

DOI: 10.1016/0006-2952(61)90145-9

Google Scholar

[10] K. Schlesier, M. Harwat, V.Böhm, R. Bitsch, Assessment of antioxidant activity by using different in vitro methods, Free Radic Res. 36:2 (2002) 177-87.

DOI: 10.1080/10715760290006411

Google Scholar

[11] Violeta Petre1, Marian Petre, Ionela Rusea, Florin Stănică, Biotechnological Recycling of Fruit Tree Wastes by Solid-State Cultivation of Mushrooms, in M. Petre (Eds.), Mushroom Biotechnology: Developments and Applications, Academic Press, Elsevier, 2016, p.19–29.

DOI: 10.1016/b978-0-12-802794-3.00002-3

Google Scholar

[12] W.C. Bak, J.H. Park, Y.A. Park, K.H. Ka, Determination of Glucan Contents in the Fruiting Bodies and Mycelia of Lentinula edodes Cultivars, Mycobiology. 42:3 (2014) 301-4.

DOI: 10.5941/myco.2014.42.3.301

Google Scholar

[13] B.V. McCleary, A. Draga, Measurement of β-Glucan in Mushrooms and Mycelial Products, J AOAC Int. 99 (2016) 364-73.

DOI: 10.5740/jaoacint.15-0289

Google Scholar

[14] S.N. Chen, C.S. Chang, M.H. Hung, S. Chen, W. Wang, C.J. Tai, C.L. Lu, The Effect of mushroom beta-glucans from solid culture of Ganoderma lucidum on inhibition of the primary tumor metastasis, Evid Based Complement Alternat Med. (2014) 2014:252171.

DOI: 10.1155/2014/252171

Google Scholar

[15] P. Anand, B. Singh, N.Singh, A review on coumarins as acetylcholinesterase inhibitors for Alzheimer's disease, Bioorg Med Chem. 20 (2012) 1175-80.

Google Scholar

[16] E.C.K. Tan, K. Johnell, S. Garcia-Ptacek, M.L. Haaksma, J. Fastbom, J.S. Bell, M. Eriksdotter, Acetylcholinesterase inhibitors and risk of stroke and death in people with dementia, Alzheimers Dement. inpress (2018) 30065-7.

DOI: 10.1016/j.jalz.2018.02.011

Google Scholar

[17] H. Khan, Marya, S. Amin, M.A. Kamal, S. Patel, Flavonoids as acetylcholinesterase inhibitors: Current therapeutic standing and future prospects, Biomed Pharmacother. 101 (2018) 860-70.

DOI: 10.1016/j.biopha.2018.03.007

Google Scholar

[18] M.A. Hasnat, M. Pervin, B.O. Lim, Acetylcholinesterase inhibition and in vitro and in vivo antioxidant activities of Ganoderma lucidum grown on Germinated Brown Rice, Molecules. 18 (2013) 6663-78.

DOI: 10.3390/molecules18066663

Google Scholar

[19] V.O. Oyetayo, O.O. Ariyo, Micro and macronutrient properties of Pleurotus ostreatus (Jacq: Fries) cultivated on different wood substrates, Jordan J Biol Sci. 6:3 (2013) 223-6.

DOI: 10.12816/0001537

Google Scholar

[20] M. Solas, E. Puerta, M.J. Ramirez, Treatment Options in Alzheimer´s Disease: The GABA Story, Curr Pharm Des. 21:34 (2015) 4960-71.

DOI: 10.2174/1381612821666150914121149

Google Scholar